Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Business > Future Prospects for Kodak

Tags

  • photos
  • would
  • cameras
  • photo cameras
  • receiving income

  • Links

  • Sports Injuries Can Be Forever
  • How to Write a Product Comparison
  • Protecting Your Corporate Image and Market Identity
  • Digg It - Future Prospects for Kodak

    Nowadays film photo cameras swiftly replace by digital ones. Despite of all advantages of digital over film cameras, professional photographers claim that photos from
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    film cameras are better. But professionals of photography present the minority on the market of photo cameras and most customers on this market are unsophisticated ama
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    eurs, which most often do not see the difference between film and digital cameras photos. Moreover, amateurs consider digital photos better and of course they apprecia
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    te all other advantages of digital cameras such as: LCD, memory cards, additional functions, digital zoom, sound and video record etc.

    Customers’ preferences drive th
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    supply and thus camera manufacturers produce more digital cameras. Kodak Company, which is one of the world leaders of photo cameras, is not an exception and “is prep
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    ring a big strategic move away from traditional film and plans to bet its future on new digital markets”. Kodak’s administration claims that Kodak stops most investmen
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    ts into film technology and enter the digital market of photography. This market is already saturated with such companies as Nikon, Olympus, Canon, Fuji etc. So which
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    rrangements will Kodak apply to occupy a worthy place on the market?

    First of all Kodak decided to behave more aggressively in order to fulfill more market segments.
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    arlier Kodak used the following targeted marketing scheme: goods- complex commercial activities- receiving income because of satisfying customers – I mean that Kodak d
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    idn’t pursued customers and sold expensive goods. Nowadays it looks like Kodak shifts to another targeted marketing scheme – receiving income from the sales volume. Th
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    s Kodak diversified its range with cheap digital products.

    Secondly, Kodak does its best in order to decrease its costs. In order to achieve this they cut the amount
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    f dividends for 62.8%. Of course, investors may sell their stock and find more profitable place for investments – this is weak point of the decision. But Kodak predict
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    s that its revenue will increase significantly in the nearest years and thus investors have an opportunity to increase their incomes – this is the strong point of cutt
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    ng dividends. The next step of cutting the costs – closing ancillary businesses and reducing the staff. The saved money Kodak invests into the development of the digit
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    l products.

    Thirdly, Kodak developed a line of digital cameras, which already gained customers’ confidence and pretend to be leaders in two price segments simultaneou
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    sly ($200 - $399 and $400 - $599 ). Additionally Kodak offers many other services for digital images – online printing, sharing and editing. These services are quite p
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    pular.

    Of course Kodak performs many other activities in order to get success on the digital market (involving in joint ventures for example) and of course all these
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    ctivities are stipulated by the increased demand on the digital cameras and accessories. Kodak chose not easy way, but even now it is already seems that the market “ac
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    cepted the new player”. Kodak’s risks are very substantial, but the bets are high and it’s too late to recede.

    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/3761/diggit-Future-Prospects-for-Kodak.html">Future Prospects for Kodak</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/3761/diggit-Future-Prospects-for-Kodak.html]Future Prospects for Kodak[/url]

    Related Articles:

    Dealing With The Public-Not Always A Barrel Of Monkeys!

    Analyzing Your Competition

    Internet Businesses For Sale

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com